Genome-wide Characterization of a Viral Cytotoxic T Lymphocyte Epitope Repertoire*

A genome-wide search using major histocompatibility complex (MHC) class I binding and proteosome cleavage site algorithms identified 101 influenza A PR8 virus-derived peptides as potential epitopes for CD8+ T cell recognition in the H-2b mouse. Cytokine-based flow cytometry, ELISPOT, and cytotoxic T lymphocyte assays reveal that 16 are recognized by CD8+ T cells recovered directly ex vivo from infected animals, accounting for greater than 70% of CD8+ T cells recruited to lung after primary infection. Only six of the 22 highest affinity MHC class I binding peptides comprise cytotoxic T lymphocyte epitopes. The remaining non-immunogenic peptides have equivalent MHC affinity and MHC-peptide complex half-lives, eliciting T cell responses when given in adjuvant and with T cell receptor-ligand avidity comparable with their immunogenic counterparts. As revealed by a novel high sensitivity nanospray tandem mass spectrometry methodology, failure to process those predicted epitopes may contribute significantly to the absent response. These results have important implications for rationale design of CD8+ T cell vaccines.

[1]  Alex Acero,et al.  Spoken Language Processing , 2001 .

[2]  R. Henderson,et al.  HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. , 1992, Science.

[3]  Jia-huai Wang,et al.  Structural basis of T cell recognition of peptides bound to MHC molecules. , 2002, Molecular immunology.

[4]  E. Pamer,et al.  Effect of antigen-processing efficiency on in vivo T cell response magnitudes. , 1998, Journal of immunology.

[5]  M. Eichelberger,et al.  Roles of alpha beta and gamma delta T cell subsets in viral immunity. , 1992, Annual review of immunology.

[6]  D. Moskophidis,et al.  Viral Escape by Selection of Cytotoxic T Cell–Resistant Variants in Influenza a Virus Pneumonia , 2000, The Journal of experimental medicine.

[7]  Hans-Georg Rammensee,et al.  MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.

[8]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[9]  Rolf M. Zinkernagel,et al.  Immunology Taught by Viruses , 1996, Science.

[10]  R. Zinkernagel,et al.  Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus , 1995, Journal of virology.

[11]  S. Kaufmann,et al.  Confrontation between intracellular bacteria and the immune system. , 1999, Advances in immunology.

[12]  P. Kloetzel,et al.  Identification of HLA-B27-Restricted Peptides from the Chlamydia trachomatis Proteome with Possible Relevance to HLA-B27-Associated Diseases1 , 2001, The Journal of Immunology.

[13]  H. Rammensee,et al.  Discrete Cleavage Motifs of Constitutive and Immunoproteasomes Revealed by Quantitative Analysis of Cleavage Products , 2001, The Journal of experimental medicine.

[14]  K. Kosmatopoulos,et al.  A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells. , 1994, Journal of immunology.

[15]  K. Garcia,et al.  T-cell receptor structure and TCR complexes. , 1997, Current opinion in structural biology.

[16]  W. Kast,et al.  Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Zinkernagel,et al.  Peptide-induced antiviral protection by cytotoxic T cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Altman,et al.  Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. , 1998, Immunity.

[19]  S. H. van der Burg,et al.  Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. , 1996, Journal of immunology.

[20]  T. Hogg,et al.  Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection. , 1997, Journal of immunology.

[21]  P. Doherty,et al.  Contemporary Analysis of MHC-Related Immunodominance Hierarchies in the CD8+ T Cell Response to Influenza A Viruses1 , 2000, The Journal of Immunology.

[22]  Alan D. Roberts,et al.  Activated Antigen-Specific CD8+ T Cells Persist in the Lungs Following Recovery from Respiratory Virus Infections1 , 2001, The Journal of Immunology.

[23]  J. Yewdell,et al.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.

[24]  Hans-Georg Rammensee,et al.  The Human 26 S and 20 S Proteasomes Generate Overlapping but Different Sets of Peptide Fragments from a Model Protein Substrate* , 2000, The Journal of Biological Chemistry.

[25]  A. Vitiello,et al.  The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.

[26]  R. Anderson,et al.  Antigen processing in vivo and the elicitation of primary CTL responses. , 1995, Journal of immunology.

[27]  N. Shastri,et al.  ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum , 2002, Nature.

[28]  D. Busch,et al.  MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. , 1998, Journal of immunology.

[29]  J. Ulmer,et al.  Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization , 1997, Journal of virology.

[30]  A. McMichael,et al.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.

[31]  E. Reinherz,et al.  Prediction of MHC class I binding peptides using profile motifs. , 2002, Human immunology.

[32]  J. Manuguerra,et al.  Protection against lethal viral infection by vaccination with nonimmunodominant peptides. , 1996, Journal of immunology.

[33]  T. Preckel,et al.  Altered Hapten Ligands Antagonize Trinitrophenyl-specific Cytotoxic T Cells and Block Internalization of Hapten-specific Receptors , 1997, The Journal of experimental medicine.

[34]  R. Krug,et al.  Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs , 1987, Journal of virology.

[35]  P. Doherty,et al.  Diversity of Epitope and Cytokine Profiles for Primary and Secondary Influenza A Virus-Specific CD8+ T Cell Responses1 , 2001, The Journal of Immunology.

[36]  R. Arlinghaus,et al.  Effects of influenza virus-specific cytotoxic T-lymphocyte responses induced by a synthetic nucleoprotein peptide on the survival of mice challenged with a lethal dose of virus. , 1994, Vaccine.

[37]  E. Pamer,et al.  CTL epitope generation is tightly linked to cellular proteolysis of a Listeria monocytogenes antigen. , 1996, Journal of immunology.

[38]  J. Altman,et al.  A Previously Unrecognized H-2Db-Restricted Peptide Prominent in the Primary Influenza A Virus-Specific CD8+T-Cell Response Is Much Less Apparent following Secondary Challenge , 2000, Journal of Virology.

[39]  J. Monaco,et al.  A molecular model of MHC class-I-restricted antigen processing. , 1992, Immunology today.

[40]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[41]  Alan D. Roberts,et al.  Antibody-Independent Antiviral Function of Memory CD4+ T Cells In Vivo Requires Regulatory Signals from CD8+ Effector T Cells1 , 2001, The Journal of Immunology.

[42]  A. Vitiello,et al.  Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. , 1996, Journal of immunology.

[43]  N. Shastri,et al.  Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. , 2002, Annual review of immunology.